Navigation Links
Octapharma Joins Biotechnology Industry Organization

CENTREVILLE, Va., Jan. 25 /PRNewswire/ -- Octapharma is pleased to announce its decision to become a member of the Biotechnology Industry Organization. Membership in BIO brings substantial benefits to Octapharma. Among these is the Association's considerable influence on the U.S. legislative process and on regulatory bodies. Representing some of the largest and most research intensive pharmaceutical companies, BIO's voice is heard where smaller groups are not. With reimbursement of biologicals becoming a significant problem in patient access to product, this influence will be critical in providing essential input into federal and state reimbursement policies and resolving access issues.

Additionally, BIO has made a concerted effort to develop a constituency of plasma derivative manufacturers. For those plasma derivative manufacturers who are currently members, BIO has become a leading source of advanced information on government and private policies relevant to the plasma derivative industry. BIO also coordinates its policy position with patient groups though its Outreach/Alliance Development Committee and other mechanisms that host regular briefings, tours and recognition events for health advocacy groups.

Finally, Octapharma believes that its decision to join BIO is consistent with its future plans and with its new mission statement, "for the safe and optimal use of human proteins." With much of the BIO membership focusing on leading edge research in genetic modifications of peptides and proteins, bioprocessing, and bioinformatics, there would appear to be great opportunities for commercial collaboration and cross-fertilization.

Octapharma welcomes the opportunity to be a part of this leading Association!

Octapharma is a leading provider of human plasma based biopharmaceuticals to healthcare professionals and consumers worldwide. Since its founding in 1983, the name Octapharma has become synonymous with ethical and responsible provision of healthcare products. We manufacture products of proven efficacy, quality and safety. More information about Octapharma can be found at

SOURCE Octapharma
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Haemonetics Becomes Preferred Provider of Plasma Collection Products to Octapharma Europe
2. Advanced Medical Specialties Joins US Oncology Network
3. Former Patent Office Solicitor and Judge Joins Rothwell Figg
4. William Garland Joins AngioGenexs New Board of Directors
5. Robin C. Stracey Joins Cantimer, Inc. as President and CEO
6. Good Neighbor Pharmacy Joins with Diversified Racing Solutions to Enter NASCAR Nationwide Series in 2008
7. Jim Dorst Joins SpectraScience as CFO
8. Chambers Joins PRA International as Senior Vice President of Human Resources
9. Brian J.G. Pereira, M.D. Joins Biodels Board of Directors
10. Dr. Joyce Sutcliffe Joins the NanoBio Team as Vice President of Research
11. SAFC Hitech(TM) Joins Aviza and ST Microelectronics for Solid State Technology ALD Webcast
Post Your Comments:
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge ... envision new ways to harness living systems and biotechnology, ... Art (MoMA) in New York City ... 130 participating students, showcased projects at MoMA,s Celeste Bartos ... Paola Antonelli , MoMA,s senior curator of architecture and ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... announced the launch of the Supplyframe Design Lab . Located in Pasadena, ... explore the future of how hardware projects are designed, built and brought to ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, ... after being treated for breast cancer benefitted from an injection of stem cells derived ... debilitating, frequent side effect of cancer treatment. , Lymphedema refers to the ...
(Date:6/23/2016)... NEWPORT BEACH, Calif. , June 23, 2016 /PRNewswire/ ... offering new biological discoveries to the medical community, has ... and co-founder Matthew Nunez . "We ... provide us with the capital we need to meet ... funding will essentially provide us the runway to complete ...
Breaking Biology Technology:
(Date:6/1/2016)... , June 1, 2016 Favorable ... Election Administration and Criminal Identification to Boost Global Biometrics ... recently released TechSci Research report, " Global Biometrics Market ... Competition Forecast and Opportunities, 2011 - 2021", the global ... by 2021, on account of growing security concerns across ...
(Date:5/12/2016)... , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
Breaking Biology News(10 mins):